|
|
Volumn 17, Issue SUPPL. E, 1996, Pages 2-8
|
|
The rationale for thrombolytic therapy
|
|
Author keywords
Acute myocardial infarction; Heparin; Myocardial reperfusion; Open vessel concept; Streptokinase; Thrombolysis; Tissue plasminogen activator
|
|
Indexed keywords
DUTEPLASE;
FIBRINOLYTIC AGENT;
HEPARIN;
HIRUDIN;
STREPTOKINASE;
TISSUE PLASMINOGEN ACTIVATOR;
ACUTE HEART INFARCTION;
ATHEROSCLEROTIC PLAQUE;
BRAIN HEMORRHAGE;
CELL DEATH;
CLINICAL TRIAL;
COLLATERAL CIRCULATION;
CONFERENCE PAPER;
EPICARDIUM;
FIBRINOLYTIC THERAPY;
HEART LEFT VENTRICLE FUNCTION;
HEART MUSCLE CELL;
HEART MUSCLE REPERFUSION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
META ANALYSIS;
MORTALITY;
NONHUMAN;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
SUBCUTANEOUS DRUG ADMINISTRATION;
SURVIVAL;
THROMBOGENESIS;
|
|
EID: 0029795769
PISSN: 0195668X
EISSN: None
Source Type: Journal
DOI: 10.1093/eurheartj/17.suppl_e.2 Document Type: Conference Paper |
|
Times cited : (9)
|
|
References (0)
|
